OR5V1, olfactory receptor family 5 subfamily V member 1, 81696
N. diseases: 23; N. variants: 20
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 6 | 29374540 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | ||||||||||
|
0.790 | 0.320 | 6 | 29388554 | intron variant | A/G | snv | 5.8E-02 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.925 | 0.160 | 6 | 29374998 | missense variant | G/A | snv | 5.5E-02 | 5.7E-02 |
|
Infections; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||
|
1.000 | 0.120 | 6 | 29368277 | intron variant | G/A | snv | 0.59 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.120 | 6 | 29373531 | 3 prime UTR variant | G/A | snv | 0.22 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
6 | 29387425 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||||
|
6 | 29387425 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||||
|
6 | 29387425 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||||
|
6 | 29387425 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||||
|
6 | 29373889 | 3 prime UTR variant | T/A | snv | 0.95 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 29357383 | intron variant | G/C | snv | 0.95 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 29357825 | intron variant | G/A | snv | 0.95 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.160 | 6 | 29374998 | missense variant | G/A | snv | 5.5E-02 | 5.7E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.790 | 0.320 | 6 | 29388554 | intron variant | A/G | snv | 5.8E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.790 | 0.320 | 6 | 29388554 | intron variant | A/G | snv | 5.8E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.790 | 0.320 | 6 | 29388554 | intron variant | A/G | snv | 5.8E-02 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.160 | 6 | 29374998 | missense variant | G/A | snv | 5.5E-02 | 5.7E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
|
1.000 | 0.080 | 6 | 29419226 | intron variant | G/T | snv | 1.9E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.790 | 0.320 | 6 | 29388554 | intron variant | A/G | snv | 5.8E-02 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.320 | 6 | 29388554 | intron variant | A/G | snv | 5.8E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.320 | 6 | 29388554 | intron variant | A/G | snv | 5.8E-02 |
|
Digestive System Diseases; Neoplasms | 0.820 | 1.000 | 4 | 2012 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 29369298 | intron variant | G/T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 29369298 | intron variant | G/T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 29387425 | intron variant | G/A;C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 29387425 | intron variant | G/A;C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 |